Pfizer Fesses Up to Cancer Risks of Xeljanz, While Valsartan Makers Keep Quiet
While Pfizer has fessed up to the inherent cancer risks of its Xeljanz pills, manufacturers of Valsartan have kept quiet about a certain ingredient that’s primarily used for rocket fuel and inducing cancer in lab rats.
At the Mass Torts Made Perfect conference in Las Vegas, RT’s Brent Jabbour sits down with attorney Sara Papantonio to discuss ongoing litigation against both companies.
#QuestionMore #RTAmerica #AmericasLawyer #MikePapantonio #SaraPapantonio #Pfizer #CancerRisk
Get exclusive content and watch full episodes now by downloading the app:
Telegram:
Check out our other shows!
NO show does it like this. It’s TIME for The News on RT America:
It’s her take on all things political and she presents ALL the angles: with Scottie Nell Hughes, NVH:
What’s your NEWS IQ? Give us 30 minutes, and we’ll take you across the globe! In Question with Manila Chan, IQ: https://bi
1 view
476
132
3 years ago 00:07:31 1
Pfizer Fesses Up to Cancer Risks of Xeljanz, While Valsartan Makers Keep Quiet